Kidney cancer AND prostate cancer
Conditions
Interventions
Gold Standard:Paraffin pathological diagnosis was used as the gold standard
Index test:Intraoperative microscopy EndoSCell™
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Study 1 1) Age>=18 years; 2) Patients who have undergone partial nephrectomy have complete clinical data, and surgical resection samples can be collected after surgery; 3) The patient understands and voluntarily signs a written informed consent form. Study 2 1) Age>=18 years; 2) Patients who underwent radical prostate cancer resection have complete clinical data, and surgical resection samples can be collected after surgery; 3) The patient understands and voluntarily signs a written informed consent form.
Exclusion criteria
Exclusion criteria: 1. Preoperative neoadjuvant therapy; 2. Other circumstances that the investigator considers inappropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Concordance between renal/prostate tumots resection margins (positive or negative) indicated by the intraoperative microscopy system Endoscells and histopathological findings (positive or negative); | — |
Countries
China
Contacts
Public ContactXuesong Li
Peking University First Hospital
Outcome results
None listed